These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22690069)

  • 41. Bile and circulating HMGB1 contributes to systemic inflammation in obstructive jaundice.
    Yang R; Zhu S; Pischke SE; Haugaa H; Zou X; Tonnessen TI
    J Surg Res; 2018 Aug; 228():14-19. PubMed ID: 29907203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target.
    Kessoku T; Kobayashi T; Tanaka K; Yamamoto A; Takahashi K; Iwaki M; Ozaki A; Kasai Y; Nogami A; Honda Y; Ogawa Y; Kato S; Imajo K; Higurashi T; Hosono K; Yoneda M; Usuda H; Wada K; Saito S; Nakajima A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease.
    Augustyn M; Grys I; Kukla M
    Clin Exp Hepatol; 2019 Mar; 5(1):1-10. PubMed ID: 30915401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.
    Nicoletti A; Ponziani FR; Biolato M; Valenza V; Marrone G; Sganga G; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Sep; 25(33):4814-4834. PubMed ID: 31543676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis.
    Sánchez E; Casafont F; Guerra A; de Benito I; Pons-Romero F
    Rev Esp Enferm Dig; 2005 Nov; 97(11):805-14. PubMed ID: 16438624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.
    Brun P; Castagliuolo I; Di Leo V; Buda A; Pinzani M; Palù G; Martines D
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G518-25. PubMed ID: 17023554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation.
    Liu L; Zhang C; Hu Y; Zhou L; Tan Q
    Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):575-583. PubMed ID: 27061671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Probiotics in non-alcoholic fatty liver disease: which and when.
    Abenavoli L; Scarpellini E; Rouabhia S; Balsano C; Luzza F
    Ann Hepatol; 2013; 12(3):357-63. PubMed ID: 23619251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
    de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
    Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature.
    Pijls KE; Jonkers DM; Elamin EE; Masclee AA; Koek GH
    Liver Int; 2013 Nov; 33(10):1457-69. PubMed ID: 23879434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier.
    Usuda H; Okamoto T; Wada K
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms and consequences of gut commensal translocation in chronic diseases.
    Fine RL; Manfredo Vieira S; Gilmore MS; Kriegel MA
    Gut Microbes; 2020; 11(2):217-230. PubMed ID: 31306081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD.
    Pierantonelli I; Rychlicki C; Agostinelli L; Giordano DM; Gaggini M; Fraumene C; Saponaro C; Manghina V; Sartini L; Mingarelli E; Pinto C; Buzzigoli E; Trozzi L; Giordano A; Marzioni M; Minicis S; Uzzau S; Cinti S; Gastaldelli A; Svegliati-Baroni G
    Sci Rep; 2017 Sep; 7(1):12200. PubMed ID: 28939830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies.
    Hodges JK; Sasaki GY; Bruno RS
    J Nutr Biochem; 2020 Nov; 85():108478. PubMed ID: 32801031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression.
    Maes M; Kubera M; Leunis JC
    Neuro Endocrinol Lett; 2008 Feb; 29(1):117-24. PubMed ID: 18283240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.
    Miele L; Valenza V; La Torre G; Montalto M; Cammarota G; Ricci R; Mascianà R; Forgione A; Gabrieli ML; Perotti G; Vecchio FM; Rapaccini G; Gasbarrini G; Day CP; Grieco A
    Hepatology; 2009 Jun; 49(6):1877-87. PubMed ID: 19291785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
    Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in Bacterial Translocation and Liver Injury in Ethanol Versus Diet-Induced Liver Disease.
    Hsu CL; Wang Y; Duan Y; Chu H; Hartmann P; Llorente C; Zhou R; Schnabl B
    Dig Dis Sci; 2023 Jul; 68(7):3059-3069. PubMed ID: 36807831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Markers of bacterial translocation in end-stage liver disease.
    Koutsounas I; Kaltsa G; Siakavellas SI; Bamias G
    World J Hepatol; 2015 Sep; 7(20):2264-73. PubMed ID: 26380651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice.
    Rubio C; Puerto M; García-Rodríquez JJ; Lu VB; García-Martínez I; Alén R; Sanmartín-Salinas P; Toledo-Lobo MV; Saiz J; Ruperez J; Barbas C; Menchén L; Gribble FM; Reimann F; Guijarro LG; Carrascosa JM; Valverde ÁM
    Mol Metab; 2020 May; 35():100954. PubMed ID: 32244182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.